AmbioPharm currently manufactures Peptide APi’s for both pharmaceutical and biotechnology companies in multiple clinical studies:

Ophthalmology Osteoporosis
Allergy / asthma Analgesia
Epilepsy Alopecia
Gynecology Vaccines
CNS disease Inflammation
Antiviral CV disease
Antibacterial Growth impairment
GI disease Diabetes
Obesity Cancer
Hemopoiesis Arthritis

AmbioPharm is also partnering with generic drug companies to develop many generic peptide drugs:

Bivalirudin
Cosyntropin
Eptifibatide
GLP-1( 7-37 )
Glucagon ( 1-29 )
Glatiramer
Leuprolide Acetate
Nesiritide
Octreotide Acetate
Thymosin alpha 1
Triptorelin Acetate
Triptorelin Pamoate
 
 
Website Design by123Triad Web Design